Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies

BACKGROUND: There is increasing interest in combining chemotherapy with immunotherapy. However, the effects of chemotherapy on the human immune system are largely unknown. METHODS: Longitudinal changes in peripheral T-cell subsets in 40 patients with malignant mesothelioma (MM) or advanced non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, M J, Lake, R A, van der Most, R G, Dick, I M, Nowak, A K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461157/
https://www.ncbi.nlm.nih.gov/pubmed/22910319
http://dx.doi.org/10.1038/bjc.2012.362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461157/
https://www.ncbi.nlm.nih.gov/pubmed/22910319
http://dx.doi.org/10.1038/bjc.2012.362

Ejemplares similares